02.1 NR vs NMN

NR vs NMN: two nicotinamide forms, two files

Technical document 02.1 · Reviewed 2026-11-19 · Nicotinamide Riboside

On this page
  1. Two structures, one phosphate apart
  2. What an assay means for each
  3. Stability questions differ
  4. The regulatory files are separate
  5. The label names the salt
  6. Choosing before the quotation

Nicotinamide riboside and nicotinamide mononucleotide are different molecules: NMN carries a 5'-phosphate that NR does not. This catalog supplies NR as the chloride salt, CAS 23111-00-4, C11H15ClN2O5, molecular weight 290.70; NMN is the free acid, CAS 1094-61-7, molecular weight 334.22. The phosphate changes the assay basis, the stability questions, the regulatory file and the label, so the two are not interchangeable.

In one line

The 5'-phosphate is the whole difference: it moves the molecular weight, the salt form, the assay basis and the regulatory file.

Two structures, one phosphate apart

NMN is the 5'-phosphorylated nucleoside; NR is the same nucleoside without the phosphate. The extra phosphate adds about 80 mass units and makes NMN an acid, so NMN is normally supplied as the free acid. NR is supplied here as the chloride salt. The two are different mass bases, not different names for the same powder.

Nicotinamide riboside chloride and NMN · the structural facts that change the file
PropertyNR chloride (this catalog)NMN
Chemical nameNicotinamide riboside chlorideβ-Nicotinamide mononucleotide
CAS number23111-00-41094-61-7
FormulaC11H15ClN2O5C11H15N2O8P
Molecular weight290.70334.22
5'-phosphateAbsentPresent
Usual supplied formChloride saltFree acid
Counter-ionChloride, 12.0–13.0%None

The comparison has one trap. 290.70 is the salt and 334.22 is the free acid, so a straight molecular-weight comparison mixes a counter-ion with a phosphate. The NR free base is 254.24; the phosphate adds about 80 units to that. When the question is the nucleoside, compare 254.24 with 334.22 and then account for the chloride separately.

What an assay means for each

Both ingredients are sold on a percentage, but the percentage is not the same measurement. NR chloride is specified at 98.0–102.0% by HPLC, with chloride at 12.0–13.0% and water at ≤2.0%. NMN is specified at ≥98.0% by HPLC, with water at ≤5.0%, a pH of 2.0–4.0 at 5% and an α/β anomer ratio read from NMR. One figure describes a salt with a counter-ion; the other describes a free acid with an anomer.

A 98.0% NR chloride result is not 98% NR by mass. About 87.5% of the salt's mass is the nicotinamide riboside moiety, so the chloride figure and the salt factor have to be applied before the label dose is calculated. On the NMN side, the anomer ratio and the water are the figures that a single HPLC percentage can hide.

Both certificates should name the column, the mobile phase, the wavelength and the standard. NR adds chloride to the panel; NMN adds the anomer and pH. A method that resolves neither the counter-ion nor the anomer has reported a peak, not a specification.

Stability questions differ

Both are water-soluble and hygroscopic, so the pack matters for both. NR chloride is specified at water ≤2.0%, which is a tighter release gate than NMN's ≤5.0%. NMN adds an ionisable phosphate and an acidic 5% solution at pH 2.0–4.0; that acidity can shift a low-buffer blend and sits beside hydrolysis and anomerisation as the first stability questions. NR brings its own salt balance and water uptake.

The handling rules overlap: a sealed, dark pack for the solid; a protected, validated solution; and a retest period drawn from data on the exact pack. The failure modes do not overlap completely, so a stability protocol for one molecule does not transfer to the other. A statement that one is more stable than the other needs a same-pack, same-method comparison; this page does not make that claim.

The regulatory files are separate

Some markets have a product-specific novel-food entry for nicotinamide riboside chloride. The buyer's regulatory team confirms the current text, the conditions of use and any maximum daily amount for the destination, and it does not accept a supplier summary as the permission. In the US, the dietary-supplement file is built around the exact ingredient and its intended use; that check is separate again.

The NMN file is separate from the NR file. A conclusion, a notification or a statement for one substance does not cover the other, and the two are reviewed on their own records. The UK register is separate again. The practical rule is to clear the molecule, the form and the market before the label is drafted.

The label names the salt

The label must name the form. “NR” alone does not say chloride, and “NMN” alone does not say β. The ingredient declaration, the assay basis and the net content have to match the specification. If the label says β-NMN and the drum contains NR, the label is wrong even when the HPLC number is high.

The two names are not synonyms on a label. A blend of NMN and NR is a third material, not a way to average the two, and it needs its own specification, its own stability data and its own regulatory review. A label change from NMN to NR is a new file, a new specification and a new stability pack, not a rename.

Choosing before the quotation

Four questions that decide between the two forms
QuestionNR chlorideNMN
Which form is named?Nicotinamide riboside chlorideβ-NMN, free acid
Which assay basis?HPLC, with chloride and waterHPLC, with anomer, pH and water
Which market file?Product-specific entry where it existsChecked on a separate record
Which pack?Hygroscopic salt; water ≤2.0%Hygroscopic acid; water ≤5.0%

Choose NR chloride when the destination permits that form, the label calls for the chloride, and the salt basis fits the dose and the pack. Choose NMN when the market permits it, the label and the specification call for β-NMN, and the method controls the anomer. Choose neither on a claim; the decision belongs to the market permission, the label, the analytical control and the dosage form.

The catalog ranges are on the NR product page; the grade choices are on the NR grades page; the certificate lines are on the COA page; the identity tests are on the identity page. The parallel file is on the NMN product page, and the dinucleotide is on the NAD page. The chromatographic method is described in the HPLC note, and the release workflow is on the quality page.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation